Daiichi Sankyo Europe GmbH
Daiichi Sankyo Europe GmbH, a subsidiary of the global pharmaceutical company Daiichi Sankyo Co., Ltd., is headquartered in Germany and operates extensively across Europe. Founded in 2005, the company has established itself in the pharmaceutical industry, focusing on innovative medicines in areas such as oncology, cardiovascular diseases, and vaccines. Daiichi Sankyo is renowned for its commitment to research and development, with a portfolio that includes unique therapies like the antibody-drug conjugate technology. This innovative approach sets them apart in the competitive landscape, allowing for targeted treatment options that enhance patient outcomes. With a strong market position, Daiichi Sankyo Europe has achieved significant milestones, including the successful launch of several key products that have made a substantial impact on patient care across the continent.
DitchCarbon Score
How does Daiichi Sankyo Europe GmbH's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Business Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Daiichi Sankyo Europe GmbH's score of 52 is higher than 62% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Daiichi Sankyo Europe GmbH, headquartered in Germany, currently does not report specific carbon emissions data for the most recent year, as no emissions figures are available. The company is a current subsidiary of Daiichi Sankyo Group, which may influence its climate commitments and initiatives. While specific reduction targets or achievements are not detailed, Daiichi Sankyo Group has established various climate initiatives, including commitments to the Science Based Targets initiative (SBTi), the Carbon Disclosure Project (CDP), and the RE100 initiative, which focuses on sourcing 100% renewable energy. These initiatives reflect a broader commitment to sustainability and reducing carbon footprints across its operations. As a subsidiary, Daiichi Sankyo Europe GmbH's climate strategies and performance may align with the overarching goals set by Daiichi Sankyo Company, Limited, which is responsible for cascading relevant climate data and targets. However, without specific emissions data or reduction targets, the company's current impact on carbon emissions remains unclear.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Scope 1 | 182,519,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 |
| Scope 2 | 290,715,000 | 000,000,000 | 000,000,000 | 000,000,000 | - | 000,000,000 | 000,000,000 | 000,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 |
| Scope 3 | 5,704,000 | - | - | - | - | - | - | - | 000,000,000 | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 |
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Daiichi Sankyo Europe GmbH is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
